Vaginal Slings Market – By Product, By Incontinence Type, By Type, By End Use – Global Forecast, 2025 to 2034

Vaginal Slings Market Size

The global vaginal slings market was valued at USD 1.8 billion in 2024. The market is anticipated to grow from USD 2 billion in 2025 to USD 4.1 billion in 2034, growing at a CAGR of 8.2% from 2025 to 2034. The high market growth is primarily attributed to growing awareness among female population about pelvic floor disorders and the available treatment options, rising prevalence of urinary incontinence, and increasing advancements in surgical techniques among other factors.
 

The market is expected to witness significant growth owing to the increasing prevalence of urinary incontinence globally. For instance, according to the data published in a NCBI article, there are more than 423 million individuals worldwide suffering from some form of urinary incontinence over the age of 20 years. This condition is highly related to the age of the person as the intensity of the condition increases as the patient grows older.
 

In addition, rise in awareness levels among females is encouraging them to get proper diagnosis and undergo treatment for incontinence. Supportive educational campaigns, government initiatives coupled with programs organized by various NGOs and women advocacy groups are contributing to creating awareness among females. Thus, better informed women seek timely treatment, thereby fueling the vaginal sings market growth.
 

Further, advancements in surgical techniques and sling designs are a key factor contributing to market growth. Development of highly advanced sling materials which are lightweight and absorbable in nature offers better patient satisfaction by reducing complexity. Furthermore, the growing demand for these procedures in outpatient settings is supporting industry growth. Factors such as shorter stays, comparatively lower cost structure as well as well-equipped facilities among other parameters are pushing the adoption of outpatient facilities.
 

Vaginal slings are medical implants that are meant to aid in the surgical management of urinary incontinence especially stress UI in females. Stress urinary incontinence is a condition defined as an involuntary loss of urine during moments where there is a sudden rise in abdominal pressure during laughing, coughing, sneezing, or exercising.
 

Vaginal Slings Market Trends

• Growing preference for minimally-invasive procedures, increasing emphasis on patient-centric care along with focus on improving the healthcare infrastructure in developing nations are among the key trends shaping the market growth positively.
   
• The healthcare sector is increasingly adopting a patient-centered approach. More focus is being placed on understanding and fulfilling the needs of the patients undergoing vaginal sling surgeries. This includes integrated approaches such as shared decision making, informed consents, and overall dialogue with the goal of improving patient experience.
   
• In addition, there is a growing preference for minimally invasive surgeries. These surgeries are also known as single-incision techniques or mini-slings as they are performed by a single vaginal incision. The patients prefer to get it done from ambulatory surgical centers owing to reduced surgical time.
   
• Moreover, other factors such as growing obese population and increase in the number of gynecological problems encountered in people of younger age groups are anticipated to fuel the market growth.
   
• Furthermore, growing focus and interest of market players in the development of technologically advanced materials for vaginal slings further boosts the market growth. For instance, in 2021, Caldera Medical, a medical device company, announced the U.S. FDA clearance for its new Desara TVez for stress urinary incontinence. Such developments are anticipated to support the market growth over the forecast period.
   

Vaginal Slings Market Analysis

In 2021, the global market was valued at USD 1.2 billion. The following year, it saw a slight increase to USD 1.4 billion, and by 2023, the market further climbed to USD 1.6 billion. Based on product, the global market is segmented into transobturator slings, tension-free vaginal tape slings, and mini-slings. The transobturator slings segment accounted for the leading market share and was valued at USD 739.2 million in 2024.
 

• The transobturator technique reduces the risk of vascular and nerve injuries that were associated with older techniques. Transobturator slings aim to increase the safety margin of the procedure by staying away from the retropubic space where significant nerves and blood vessels are situated. This is expected to positively increase the segmental growth in the market.
   
• Further, several key players in the market are offering advanced transobturator slings to treat urinary incontinence in women. For instance, Boston Scientific Corporation offers Obtryx II a transobturator mid-urethral sling system with a 'PrecisionBlue' design offering wide range of features including improved physician visualization for accurate sling placement, smooth sling placement, and intra-operative adjustability designed for minimal tissue disruption.
   
• Moreover, transobturator slings are particularly famous for their minimally invasive approach. The sling is placed through small incisions made in the groin, so no larger abdominal incisions are required. Patients tend to prefer minimally invasive therapies compared to traditional open surgical treatments because of fewer complications, reduced discomfort after the surgery, and quicker recovery time.
   

Based on incontinence type, the global vaginal slings market is categorized into stress incontinence, mixed incontinence, and urge incontinence. The stress incontinence segment dominated the market with 41.2% market share in 2024.
 

• Ageing increases the possibility of muscle changes in the pelvic region which increases the risk of stress urinary incontinence in the elderly population. As the elderly population across the globe is growing, it is in turn resulting in surged up target population for stress urinary incontinence.
   
• Stress urinary incontinence is among the most prevalent form of urinary incontinence in the world. For instance, according to the published data, more than 15 million adult women in the U.S. are suffering from stress UI. Thus, in order to manage this condition especially among the older age groups, vaginal slings play a key role thereby fueling market growth.
   
• Moreover, the growing public health concern regarding female urological diseases, especially painful bladder syndrome (PBS), has led to a greater focus on scientific research of the issue. This increased focus results in greater initiatives towards improved diagnosis, treatment, and management including the use of vaginal slings which enhances the management of stress incontinence.
   

Based on type, the global vaginal slings market is categorized into midurethral sling and traditional sling. The midurethral sling segment held leading revenue share in the market in 2024 and is expected to reach USD 3 billion by 2034.
 

• Midurethral slings are regarded as having high efficacy in the management of stress urine incontinence. Number of clinical trials and observational studies document the effectiveness of midurethral slings for the improvement of continence care and quality of patient's life, making them preferred options for both healthcare providers and patients.
   
• The midurethral slings are considered to be effective and safe in the treatment of stress urinary incontinence. For instance, midurethral slings can cure or significantly recover stress urinary incontinence in around 80% to 90% of women. It is as effective as traditional sling procedures such as Burch colposuspension and pubovaginal fascial tissue slings.
   
• Additionally, mid-urethral sling procedures are well known for being less invasive. These techniques usually involve small surgical cuts which lead to quicker recovery time, less postoperative pain, and faster resumption of normal life compared to an open surgery. The minimally invasive nature of these procedures significantly improves patient's satisfaction post-surgery.
   
• Furthermore, these slings are long-lasting up to 17 years, with a high satisfaction rate and no serious long-term sling-associated complications.
   

Based on end use, the global vaginal slings market is classified into hospitals, clinics and ambulatory surgical centers. In 2024, the hospitals segment held highest market share and is expected to showcase significant growth over the analysis period.
 

• Hospital facilities are equipped with well-trained healthcare professionals and surgeons along with advanced surgical equipment for a wide range of procedures. Governments of various countries are investing in improving the overall healthcare infrastructure to offer quality services to the citizens by increasing the number of hospitals and similar settings. For instance, in May 2023, Burjeel Medical City in collaboration with IFEM Endo launched an advanced gynecology institute in the UAE to provide quality medical services to women in the country. Such initiatives are expected to boost the segmental growth over the forecast period.
   
• Moreover, hospitals allocate funds towards the training and education of health care practitioners, including surgeons and nurses, to ensure they are skilled in the vaginal sling surgical procedure. Hence, all the above parameters are anticipated to fuel the industry growth.
   

The North America vaginal slings market was valued at USD 428.3 million in 2024. The market is driven by availability of better reimbursement facilities, high patient population for stress incontinence, use of technologically advanced materials in vaginal slings and increasing geriatric population in the region.
 

The U.S. market was valued at USD 267.6 million and USD 314.9 million in 2021 and 2022, respectively. The market size reached USD 396.8 million in 2024, growing from USD 357 million in 2023.
 

• Increasing numbers of women suffering from stress urinary incontinence (SUI), especially the older age group, is driving the U.S. market growth. Also, increased awareness of pelvic health and the presence of specialized urogynecology clinics has encouraged more women suffering from urinary incontinence to receive treatment. The demand for surgical treatments such as vaginal slings is rising due to increased pelvic floor disorders among women due to several pointers such as obesity, childbirth, and menopause.
   
• Moreover, the adoption of new surgical and sling material techniques, such as minimally invasive approaches, are improving patient outcomes and reducing recovery period which further boosts the market growth.
   
• Further, favorable reimbursement scenario coupled with availability of well-established healthcare infrastructure is facilitating the market growth.
   

Europe vaginal slings market accounted for majority revenue share and was valued at USD 677.5 million in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• The increasing awareness related to women’s health and the rise of dedicated urogynecology clinics have motivated patients for early diagnosis and treatment, encouraging more patients.
   
• The presence of key medical device manufacturers, ongoing clinical research and regulatory approvals for innovative designs and materials of the vaginal slings provide further support for expansion of the regional market.
   
• Moreover, the growing demand towards private healthcare facilities and the rise of medical tourism for sophisticated procedures in urogynecology is anticipated to foster the demand for vaginal slings in Europe.
   

The UK vaginal slings market is expected to witness considerable growth over the analysis period.
 

• The market in the UK is projected to grow significantly over the forecast period owing to factors such as rising rates of stress urinary incontinence (SUI), growing elderly population, and rise in number of patients suffering from gynecological issues.
   
• Additionally, the increasing rate of obesity, which is a common risk factor for pelvic floor disorders, is aiding market growth. Further, the country’s nationalized healthcare system, which also covers various incontinence treatment procedures, provides adequate support for vaginal sling procedures, thereby fueling the industry demand.
   
• Moreover, increasing preference for single incision techniques as it reduces complication and recovery time after surgery is another parameter propelling the market growth.
   

The Asia Pacific vaginal slings market is anticipated to grow at the highest CAGR of 9.1% during the analysis timeframe.
 

• Growth in the volume of procedures is being driven by the rise in number of outpatient surgical centers, specialty clinics coupled with favorable reimbursement landscape in key regional countries is supporting the growth of Asia Pacific market.
   
• Additionally, innovation in new product development such as novel vaginal slings further fuels the research and development spending by leading industry stakeholders is expected to spur the product demand.
   
• Furthermore, increasing usage of vaginal slings procedures is being reported in the region due to greater accessibility of these services to affected patients. The growth of the market has also been fueled by greater advocacy for synthetic and biologic slings instead of traditional, thereby contributing to overall industry growth.
   

China vaginal slings market is predicted to grow significantly over the forecast period.
 

• The benefit of capabilities of local medical devices manufacturers aids in decreasing the overall costs of surgical procedures. These cost-effective procedures have only contributed to the growing procedural volume in private healthcare institutions as well as increasing medical tourism.
   
• In addition, the increased use of biocompatible and adjustable tension slings as well as other advance sling materials have improved the outcomes of surgeries and overall patient satisfaction.
   
• Further, the long-term plan of Chinese government towards healthcare reforms in the country and improving spending on healthcare facility construction has provided better access to surgeries, resulting in market growth.
   

Brazil is experiencing significant growth in the Latin America vaginal slings market and is anticipated to record robust growth throughout the forecast period.
 

• The number of surgeries performed is expected to increase due to growing awareness levels of urinary incontinence among elderly women and emerging treatment options.
   
• In addition, the rise in disposable income, growing prevalence of urinary incontinence in the country is anticipated to spur industry growth. For instance, according to the reported statistics, there are over 10 million patients suffering from some form of urinary incontinence in Brazil. The percentage of women patients is on a higher side in comparison to males.
   
• Moreover, consistent investment in health infrastructure coupled with supportive government policies are other points contributing to market growth.
   

Saudi Arabia vaginal slings market is poised to witness substantial growth in Middle East and Africa market during the forecast period.
 

• Increase in younger female population suffering from various gynecology issues is a key variable supporting the industry growth in Saudi Arabia. Increase in patients with different gynecology issues have a greater risk of developing incontinence related symptoms in their lifetime. Hence, the growing disease burden is projected to fuel the industry growth over the analysis period in Saudi Arabia.
   
• Further, the high adoption of technologically advanced mini-Slings is supporting the increased product demand.
   
• Moreover, the rise in awareness about availability of different treatment options is another pointer propelling the industry growth.
   

Vaginal Slings Market Share

The market is competitive in nature and is dominated by major multinational global players such as Coloplast, Johnson & Johnson, Boston Scientific, and neomedic international among others. These players contribute around 30% of market share. The vaginal slings industry is highly competitive with the presence of both larger multinational corporations and smaller medium-sized businesses eyeing for a share in the industry. The primary focus of the competition is the development and introduction of new sophisticated products utilizing novel technologies and materials. A notable market presence is shared by B. Braun Melsungen AG, Betatech Medical, Promedon, Caldera Medical, and many more of the industry players.
 

Vaginal Slings Market Companies

Few of the prominent players operating in the vaginal slings industry include:

• ADLER
• A.M.I.
• B. Braun
• Betatech
• Boston Scientific
• CALDERA MEDICAL
• Coloplast
• COUSIN SURGERY
• Johnson&Johnson
• LOTUS
• neomedic international
• Promedon
• UNISUR
• UroCure
   
• Boston Scientific Corporation: Known for inventive medical prosthesis, Boston Scientific specializes in offering a variety of vaginal slings for stress urinary incontinence which are aimed towards achieving comfort and treating patients effectively using minimally invasive procedures.
   
• Coloplast Corp: Intimate healthcare is the forte of Coloplast and in that area, they provide some of the best quality vaginal slings which, due to their biocompatibility and patient-centered designs, are easier to use and improve results while reducing recovery times.
   

Vaginal Slings Industry News

• In January 2024, UroCure and LiNA Medical U.S. launched two new surgical solutions for female stress urinary incontinence nationwide. This product launch may enable the company to improve its product portfolio and industry position in the country.
   
• In May 2023, Caldera Medical, a company of PlantTec Medical, introduced polysaccharide-based product 4DRYFIELD to effectively stop bleeding and prevent postoperative tissue adhesions in surgeries including vaginal sling procedures.
   

The vaginal slings market research report includes in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Market, By Product

• Transobturator slings
• Tension-free vaginal tape slings
• Mini-slings

Market, By Incontinence Type

• Stress incontinence
• Mixed incontinence
• Urge incontinence   

Market, By Type

• Midurethral sling
• Traditional sling

Market, By End Use

• Hospitals
• Clinics
• Ambulatory surgical centers

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea

• Latin America
  • Brazil
  • Mexico
  • Argentina

• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE